Although we did not examine reversal of fibrosis in the current study, our findings extend these previous reports of the beneficial effects of BET inhibition on fibrosis to the STAM model, which more closely mirrors human NASH progression. Here, DNER is linked to metabolic dysfunction-associated steatohepatitis.